ADP-ribosylation from molecular mechanisms to therapeutic implications - Aspects Moléculaires du Vivant
Article Dans Une Revue Cell Année : 2023

ADP-ribosylation from molecular mechanisms to therapeutic implications

Résumé

ADP-ribosylation is a ubiquitous modification of biomolecules, including proteins and nucleic acids, that regulates various cellular functions in all kingdoms of life. The recent emergence of new technologies to study ADP-ribosylation has reshaped our understanding of the molecular mechanisms that govern the establishment, removal, and recognition of this modification, as well as its impact on cellular and organismal function. These advances have also revealed the intricate involvement of ADP-ribosylation in human physiology and pathology and the enormous potential that their manipulation holds for therapy. In this review, we present the state-of-the-art findings covering the work in structural biology, biochemistry, cell biology, and clinical aspects of ADP-ribosylation.
Fichier principal
Vignette du fichier
PIIS0092867423009625.pdf (5.03 Mo) Télécharger le fichier
Origine Publication financée par une institution
licence

Dates et versions

hal-04310798 , version 1 (27-11-2023)

Licence

Identifiants

Citer

Marcin J Suskiewicz, Evgeniia Prokhorova, Johannes G M Rack, Ivan Ahel. ADP-ribosylation from molecular mechanisms to therapeutic implications. Cell, 2023, 186, pp.4475 - 4495. ⟨10.1016/j.cell.2023.08.030⟩. ⟨hal-04310798⟩
56 Consultations
30 Téléchargements

Altmetric

Partager

More